Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 56NIH 8NETWORK 4INDUSTRY 4

Study Type

Observational 7Interventional 4Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 1

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Interventions

Paclitaxel 2Carboplatin 2pertuzumab 1pemigatinib 1olaparib 1ivosidenib 1ipatasertib 1entrectinib 1cobimetinib 1belinostat 1atezolizumab 1alectinib 1Vemurafenib 1Mebendazole 1HhAntag691 1Gemcitabine 1Erlotinib Hydrochloride 1Cisplatin 1CP protocol 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Neoplasms, Unknown Primary × Clear all
NCT03498521 2025-11-19

CUPISCO

Hoffmann-La Roche

Phase 2 Completed
529 enrolled 16 charts
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT03053466 2022-05-09

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

Apollomics (Australia) Pty. Ltd.

Phase 1 Completed
30 enrolled

Turcot syndrome, Neoplasms, Unknown Primary, Microsatellite Instability

NCT03628079 2020-01-22

RepoMeb

Repos Pharma

Phase 1/2 Terminated
11 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms, Unknown Primary

NCT00873119 2015-07-28

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Valerio Therapeutics

Phase 2 Completed
89 enrolled 12 charts
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡